Cervical cancer trials in China

In China 159 Also abroad 532

159 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Modified Tumor-free Techniques Operation to Cervical Cancer
Where
Beijing, Cangzhou, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Lanzhou, Nanchong, Shanghai, Shijiazhuang, Tianjin, Wuhan, Xi’an, Xianyang
Age
18 years to 65 years
People
524
Run by
Peking Union Medical College Hospital
See details and how to joinNCT06836869
Phase 2Not yet taking people in China
JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer
Where
Guangzhou, Hangzhou
Age
18 years and over
People
78
Run by
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
See details and how to joinNCT07497074
No phaseNot yet taking people in China
A Single-arm, Multicenter, Phase II Clinical Study of Camrelizumab Combined With Famitinib in Adjuvant Therapy After Radical Resection of Cervical Cancer
Where
Shanghai
Age
18 years to 75 years
People
30
Run by
Jin LI
See details and how to joinNCT07466901
Phase 1/2Taking people
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Where
Beijing, Chengdu, Chongqing, Fuzhou, Haikou, Heilongjiang, Henan, Hunan, Shanghai
Age
18 years to 80 years
People
54
Run by
Sichuan Enray Pharmaceutical Sciences Company
See details and how to joinNCT07433283
No phaseTaking people
Transcutaneous Electrical Acupoint Stimulation for Postoperative Urinary Retention After Radical Surgery for Cervical Cancer
Where
Hangzhou
Age
18 years to 70 years
People
76
Run by
Lu Chao
See details and how to joinNCT07235371
Phase 2Not yet taking people in China
A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer
Where
Wuhan
Age
18 years to 75 years
People
32
Run by
Zhongnan Hospital
See details and how to joinNCT07363330
Phase 2Taking people
A Study of BL-B01D1 + Pembrolizumab ± Bevacizumab in Patients With Recurrent or Metastatic Cervical Cancer and Endometrial Cancer
Where
Shanghai
Age
18 years to 75 years
People
96
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07054567
Phase 2Not yet taking people in China
A Phase II Study of Neoadjuvant Sacituzumab Tirumotecan in Combination With Iparomlimab and Tuvonralimab in Locally Advanced Cervical Cancer
Where
Guangzhou
Age
18 years to 65 years
People
25
Run by
Zheng Min
See details and how to joinNCT07348861
Phase 1Taking people
The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies
Where
Wuhan
Age
18 years and over
People
97
Run by
Tongji Hospital
See details and how to joinNCT06552598
Phase 2Taking people
Serplulimab for Locally Advanced Cervical Cancer
Where
Tianjin
Age
18 years to 75 years
People
216
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07340489
Phase 2Taking people
Online Adaptive Radiotherapy for Cervical Cancer
Where
Beijing
Age
18 years to 80 years
People
124
Run by
Peking Union Medical College Hospital
See details and how to joinNCT06562166
Phase 2Taking people
Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors
Where
Tianjin
Age
18 years to 65 years
People
134
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06727617
Phase 1/2Taking people
Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors
Where
Guangzhou
Age
18 years to 75 years
People
60
Run by
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT06938880
Phase 1/2Taking people
Study of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical Cancer
Where
Hangzhou
Age
18 years to 75 years
People
120
Run by
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT07080216
Phase 2Taking people
Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial
Where
Hangzhou
Age
18 years to 70 years
People
59
Run by
Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT07167160
Phase 2Taking people
QL1706 Plus Chemotherapy as Neoadjuvant Therapy for Locally Advanced Cervical Cancer: A Phase II Trial
Where
Guangzhou
Age
18 years to 70 years
People
50
Run by
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
See details and how to joinNCT07286253
No phaseTaking people
The Effects of Immunonutrition Therapy on Locally Advanced Cervical Cancer Patients
Where
Beijing
Age
18 years and over
People
50
Run by
SHUANG ZHENG JIA, PhD
See details and how to joinNCT06349148
Phase 2Taking people
Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC
Where
Beijing
Age
18 years to 75 years
People
30
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07232654
Phase 1Taking people
Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors
Where
Shanghai
Age
18 years to 75 years
People
12
Run by
Therorna
See details and how to joinNCT07081984
Phase 2Not yet taking people in China
Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer
Where
Hangzhou
Age
18 years and over
People
42
Run by
Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT07244965
Phase 2Taking people
A Phase II Trial of SHR-A1811 in HER2-Expressing Recurrent/Metastatic Cervical Cancer
Where
Fuzhou, Jinan
Age
18 years to 75 years
People
60
Run by
Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07051486
Phase 1/2Not yet taking people in China
Penfluridol for Relapsed/Refractory Small Cell Cancers
Where
Wuhan
Age
18 years to 75 years
People
33
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07206563
Phase 1/2Taking people
A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies
Where
Shanghai
Age
18 years to 75 years
People
38
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT05803018
Phase 2Taking people
A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Cervical Cancer and Other Gynecological Malignancies
Where
Beijing
Age
18 years to 75 years
People
130
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT05990803
Phase 2Not yet taking people in China
Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer
Where
Beijing
Age
18 years to 70 years
People
180
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07088731